AMYLOIDOSIS

Read 1383 times

1. A Phase 3, Randomized, Controlled, Open-label, Multicenter, Safety and Efficacy Study of Dexamethasone Plus MLN9708 or Physicians Choice of Treatment Administered to Patients With Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis

Study Locations in Greece:
Department of Clinical Therapeutics, «Alexandra» Hospital, Athens
Hematology Unit of Internal Medicine Dept. - University General Hospital of Patras